0000899243-22-011461.txt : 20220317
0000899243-22-011461.hdr.sgml : 20220317
20220317185743
ACCESSION NUMBER: 0000899243-22-011461
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220315
FILED AS OF DATE: 20220317
DATE AS OF CHANGE: 20220317
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Aguilar Richard
CENTRAL INDEX KEY: 0001865481
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39289
FILM NUMBER: 22750374
MAIL ADDRESS:
STREET 1: 9725 NW 117TH AVENUE, SUITE 200
CITY: MIAMI
STATE: FL
ZIP: 33178
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cano Health, Inc.
CENTRAL INDEX KEY: 0001800682
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9725 NW 117TH AVENUE, SUITE 200
CITY: MIAMI
STATE: FL
ZIP: 33178
BUSINESS PHONE: 2034227700
MAIL ADDRESS:
STREET 1: 9725 NW 117TH AVENUE, SUITE 200
CITY: MIAMI
STATE: FL
ZIP: 33178
FORMER COMPANY:
FORMER CONFORMED NAME: Jaws Acquisition Corp.
DATE OF NAME CHANGE: 20200121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-03-15
0
0001800682
Cano Health, Inc.
CANO
0001865481
Aguilar Richard
CANO HEALTH, INC.
9725 NW 117TH AVENUE
MIAMI
FL
33178
0
1
0
0
Chief Clinical Officer
Class A Common Stock
2022-03-15
4
A
0
171641
A
889870
D
Stock Option (Right to Buy)
6.03
2022-03-15
4
A
0
37320
0.00
A
2032-03-15
Class A Common Stock
37320
37320
D
These shares represent restricted stock units ("RSUs") granted under the Cano Health, Inc. 2021 Stock Option and Incentive Plan. Each unit represents a right to receive one share of the Issuer's Class A Common Stock. The RSUs vest as to 50% of the RSUs on December 31, 2022 and the remaining 50% of the RSUs vest on December, 31, 2023. The RSUs were granted on March 15, 2022.
The stock option is granted under the Cano Health, Inc. 2021 Stock Option and Incentive Plan and is scheduled to vest over four years, with 25% of the shares underlying the award vesting on March 15, 2023, and 25% of the shares underlying the award vesting at the end of each successive one-year period thereafter. The stock option was granted on March 15, 2022.
/s/ David J. Armstrong, Attorney-in-Fact
2022-03-17